BETASLEEP - SLEEP Quality and Functional Health Status, Fatigue, Comorbidities and Therapeutic Algorithms Among BETAferon Treated MS Patients
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms BETASLEEP
- Sponsors Bayer
- 24 Mar 2017 Status changed from active, no longer recruiting to completed.
- 23 Jun 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 23 Dec 2014 Planned End Date changed from 1 Dec 2017 to 1 Mar 2017 as reported by ClinicalTrials.gov record.